Abstract 722: Epidemiological characterization of renal cell carcinoma in Hispanics: A single US center cohort study
Authors: Murray Abner A. , Gallegos Jesus A. Ocejo , Jones Sandra , Noy Jose , Frias Rosa L. , Campoverde Leticia E. , Merchan Jaime R. 
Published: April 2023

Abstract
Background: Annually, there are over 400,000 new cases of renal cell carcinoma (RCC) and more than 170,000 deaths worldwide. RCC is one of the top ten more prevalent malignancies in the United States, with 76,000 new cases each year and almost 14,000 deaths. Over the past half-century, RCC has more than doubled in incidence. RCC seems to have a greater incidence among Hispanics with a nearly three-fold increase. The epidemiology of RCC in the Caucasian population has been previously studied. However, there is a knowledge gap on disparities in RCC on minority populations. Studying the epidemiology of RCC in Hispanics is integral to our community where Hispanics make up 70%.
Methods: We conducted a retrospective cohort study to describe the characteristics and rates of recurrence of RCC among patients treated at Sylvester Comprehensive Cancer Center in Miami (which serves four counties in South Florida) between June 2010 to June 2022. We identified ethnicity as Hispanic/Latino (HL) or non-Hispanic/Latino (NHL). Clinical presentation was classified based on the last encounter as local RCC without recurrence, metastatic RCC after nephrectomy, and metastatic RCC at diagnosis/de novo.
Results: We analyzed a total of 2049 patients aged 18 and older diagnosed with RCC, from which 1014 patients (47.90%) were identified as NHL and 933 (48.02%) as HL. A subtotal of 435 patients (22.86%) had metastatic RCC at diagnosis/de novo, from which 245 (55.60%) were NHL, and 176 (40.57%) were HL. A subtotal of 1614 patients (77.14%) were diagnosed with local RCC and underwent nephrectomy, from which 769 (45.61%) were identified as NHL and 787 (50.22%) as HL.
From the NHL group that underwent nephrectomy, 223 patients (28.28%) had recurrent disease, and 546 patients (71.72%) did not. From the HL group, 176 patients (21.81%) had recurrent disease, and 611 (78.19%) did not. Overall, 409 patients had metastasis after nephrectomy, of which 176 (44.5%) were HL, and 203 (52.42%) were NHL.
Conclusions: In this cohort of patients with RCC, almost 50% of patients diagnosed with metastasis were HL. NHL appeared to have more disease recurrence after nephrectomy and higher rates of metastatic disease at diagnosis compared to Hispanics. Further histopathological differences, clinical outcomes, genomic characterization, and rates of clinical trial participation between the NHL and HL cohorts will be presented at the meeting, along with comparisons between US and foreign-born HLs.
Citation Format: Abner A. Murray, Jesus A. Ocejo Gallegos, Sandra Jones, Jose Noy, Rosa L. Frias, Leticia E. Campoverde, Jaime R. Merchan. Epidemiological characterization of renal cell carcinoma in Hispanics: A single US center cohort study [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 722.